Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulation and Law

Set Alert for Regulation and Law

TINA.org Alleges Gillette Products Are 'Wicked Imported,' Not Made In USA

P&G's Gillette says "we don't just market blades, we've been making them right here in Boston for over 100 years." That may be the case, but Truth in Advertising says the brand does not disclose that the majority of its products are not "all or virtually all" made in the US as its ads suggest, a finding the NGO has referred to FTC.

Advertising, Marketing & Sales Legal Issues Consumer

California DTSC Official Says Nail Care Will Remain SCP Focus Area; Stakeholders Stay Tuned

Under California's Safer Consumer Products regulation, nail care remains the segment of leading interest in the broader personal-care category, which will again be listed as a focal area in the Department of Toxic Substances Control's 2018-2020 work plan expected in draft form in February. DTSC's Meredith Williams discusses.

State News Regulation Cosmetic Ingredients

AHPA Offers Regulatory Suggestions: Health And Wellness Industry News

AHPA makes regulatory recommendations across supplement sector; CRN's Al-Mondhiry joins Amin Talati Upadhye; and Ismail moves from GOED.

International United States Dietary Supplements
Advertisement

Regulation

Set Alert for Trademarks Regulation

Latest From Regulation

NAFTA’s Been Good To Cosmetics And Could Get Better, But Stars Are Not Aligning In 2018

It appears that hopes may be dashed for a fast-tracked NAFTA update, putting the trade agreement’s future in question. The cosmetics industry has much to gain from the reboot, which stands to include an annex promoting regulatory best practices and other principles for "cost savings and greater competitiveness for our industry," according to PCPC leadership.

North America Trade

Capitol Hill Calm On Regulatory Front Before Mid-Term Elections Storm

Federal agencies have “put brakes on new regulations” during the Trump administration and made efforts toward deregulation across the board, bringing about a “good and friendly environment for most businesses and industries,” says lobbyist Pete Evich. “We need to be careful about complacency that has a tendency to creep back in at a time like this when direct attacks and threats are down,” he said in a recent webinar.

Regulation Manufacturing

Carmex Cold Sore Treatment Claims Exceed Monograph Limit In NAD Review

Carma Labs’ Carmex Cold Sore Treatment claims did not mirror language in two OTC monographs for its active ingredients, the National Advertising Division says in a review of packaging and advertising claims challenged by GlaxoSmithKline's consumer business.

Regulation Consumer

OTC Monograph Reform Could ‘Unlock’ Innovations In Three Years

Following enactment of US OTC monograph reform, drug companies will unleash formulation innovations after keeping a lid on monograph R&D, CHPA anticipates. "A lot of companies have ideas like this they’ve kind of put in a drawer, that we think this is gonna unlock,” says David Spangler, an executive with the OTC trade group.

Regulation Consumer

OTC Monograph Legislation Clears Another Hurdle Despite Exclusivity Concerns

Democrats' opposition to the length of the exclusivity allowed for some new monograph products didn't stop them from voting to send US OTC monograph overhaul legislation on for a vote by the full House. House/Senate differences and some members' questions on whether new exclusivity is needed could make it harder for reforms to pass this year.

Regulation Consumer

Massachusetts Bid Stalls To Age-Restrict Sales Of Bodybuilding, Weight Loss Supplements

"We spent a lot of time in Massachusetts trying to point out the flaws in the legislation," says CRN government relations chief Mike Greene. CRN and other stakeholders could focus on the Massachusetts bill because no other similar proposals surfaced in other state legislatures this year.

Dietary Supplements State News
See All

Legislation

Set Alert for Legislation

Latest From Legislation

‘Something’s Going To Happen’: Former FDAer John Bailey On Cosmetics Reform Legislation

ICMAD leadership agrees with Bailey that, now more than ever before, the pieces are in place for cosmetics reform legislation to reach the finish line. At the same time, the small-business advocate remains opposed to leading proposals, signaling the significant distance that negotiations may still have to go.

Legislation Consumer

Capitol Hill Calm On Regulatory Front Before Mid-Term Elections Storm

Federal agencies have “put brakes on new regulations” during the Trump administration and made efforts toward deregulation across the board, bringing about a “good and friendly environment for most businesses and industries,” says lobbyist Pete Evich. “We need to be careful about complacency that has a tendency to creep back in at a time like this when direct attacks and threats are down,” he said in a recent webinar.

Regulation Manufacturing

OTC Monograph Reform Could ‘Unlock’ Innovations In Three Years

Following enactment of US OTC monograph reform, drug companies will unleash formulation innovations after keeping a lid on monograph R&D, CHPA anticipates. "A lot of companies have ideas like this they’ve kind of put in a drawer, that we think this is gonna unlock,” says David Spangler, an executive with the OTC trade group.

Regulation Consumer
See All

Legal Issues

Set Alert for Legal Issues

Latest From Legal Issues

SPF Fraud Cases Hard To Shake, Could Shine Light On FDA Protocol Problems

As SPF defendants’ dismissal motions continue to be shot down in federal courts, it increasingly seems that their SPF claims and the radically different test results alleged by plaintiffs will have to be subjected to rigorous analysis and expert opinion, undertakings that could shine light on inherent problems with FDA’s testing protocol rather than overt moves by companies to inflate the protective capacity of their products.

Legal Issues Consumer

SPF Claims No More Reliable In 2018 Than Previous Years – Consumer Reports

The nonprofit publication’s 2018 sunscreen ratings and buying guide reflect its own SPF testing in which a third of sunscreens again underperformed dramatically compared with labeled SPFs. Low-scoring brands may face a new wave of false-advertising litigation, with many related suits still pending in federal and state courts.

Legal Issues Advertising, Marketing & Sales

Rodan + Fields Concealed Prostaglandin Risks From Lash Boost Users – Class Action

Marketers of cosmetic lash enhancers that haven’t abandoned prostaglandin analogs in favor of peptides or botanical extracts should take heed of a proposed class action against Rodan + Fields in California’s Northern District. Plaintiffs say they would not have purchased the firm’s Lash Boost and suffered alleged adverse effects if they’d been properly informed about product risks.

Legal Issues Advertising, Marketing & Sales
See All
UsernamePublicRestriction

Register